475085-56-4

Basic information

• Product Name: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-, 1,1-dimethylethyl ester
• CAS NO: 475085-56-4
• Molecular Formula: C18H26ClNO3
• Molecular Weight: 339.862
• Mol File: 475085-56-4.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-, 1,1-dimethylethyl ester(475085-56-4)
• EPA Substance Registry System: 1-Piperidinecarboxylic acid, 4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-, 1,1-dimethylethyl ester(475085-56-4)

Safety Data

• Hazardous Substances Data: 475085-56-4(Hazardous Substances Data)

Upstream product

• 173186-91-9 N-benzyl-3,3-dimethylpiperidine-4-one 
• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 
• 106-39-8 bromochlorobenzene 
• 324769-06-4 tert-butyl 3,3-dimethyl-4-oxopiperidine-1-carboxylate 
• 873-77-8 (4-chlorphenyl)magnesium bromide 

Downstream Products

• 690660-21-0 4-(4-chloro-phenyl)-3,3-dimethyl-piperidin-4-ol 
• 946590-47-2 C₂₅H₃₂ClN₃O₃ 
• 946585-01-9 C₂₅H₃₀Cl₂N₂O₃ 
• 946584-96-9 C₂₅H₃₀Cl₂N₂O₃ 
• 1443511-42-9 (S)-1-tert-butyl 2-((1R,3R)-3-((R)-1-((S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl)-3-methyl-1-oxobutan-2-ylcarbamoyl)cyclopentyl) pyrrolidine-1,2-dicarboxylate 
• 946583-44-4 C₂₅H₃₀Cl₂N₂O₃ 
• 946585-20-2 C₂₅H₃₂ClN₃O₅S 
• 946594-71-4 C₂₆H₃₁ClN₂O₅ 
• 946585-00-8 C₂₆H₃₁ClN₂O₅ 
• 946587-22-0 C₂₄H₃₀ClN₃O₃ 
• 946587-16-2 C₂₄H₃₀ClN₃O₃ 
• 946587-18-4 C₂₄H₃₀ClN₃O₃ 
• 946585-18-8 C₂₆H₃₃ClN₂O₃ 
• 946585-15-5 C₂₇H₃₅ClN₂O₃ 

Relevant articles and documents

CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

PRODRUGS OF A PIPERIDINYL DERIVATIVE AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present application describes prodrugs of the compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well a

PIPERIDINYL DERIVATIVE AS A MODULATOR OF CHEMOKINE RECEPTOR ACTIVITY

The present application describes the compound of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune